Invanz TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: ertapenem
Pack: Invanz 1 g powder for injection, 1 vial
Brand name
(ARTG)
: INVANZ ertapenem (as sodium) 1g powder for injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INVANZ is indicated for the treatment of adult patients with moderate to severe infections caused by susceptible strains of microorganisms, which are suspected or proven to be resistant to all other antibiotics, or for patients unable to tolerate other antibiotics. INVANZ is also indicated for initial empiric therapy for the treatment of complicated intra-abdominal infections and acute pelvic infections including post-partum endomyometritis, septic abortion and post-surgical gynaecological infections. Appropriate specimens for bacteriological examination should be obtained in order to isolate and identify the causative organisms and to determine their susceptibility to ertapenem. Therapy with INVANZ may be initiated empirically before the results of these tests are known; once these results become available, antimicrobial therapy should be adjusted accordingly.,INVANZ is indicated for the treatment of patients, aged 3 months or more, with moderate to severe infections (except meningitis, see PRECAUTIONS) caused by susceptible strains of micro-organisms which are suspected or proven to be resistant to all other antibiotics, or for patients unable to tolerate other antibiotics. INVANZ is also indicated for initial empiric therapy for the treatment of complicated intra-abdominal infections and acute pelvic infections including post-partum endomyometritis, septic abortion and post-surgical gynaecological infections. INVANZ is also indicated for Treatment of diabetic foot infections, which require parenteral antibiotic therapy and are caused by susceptible bacterial pathogens which are suspected or proven to be resistant to all other registered antibiotics, or for patients unable to tolerate other antibiotics. Appropriate specimens for bacteriological examination should be obtained in order to isolate and identify the causative organisms and to determine their susceptibility to ertapenem. Therapy with INVANZ may be initiated empirically before the results of these tests are known; once these results become available, antimicrobial therapy should be adjusted accordingly.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Intravenous
- Solid, white to off-white, essentially uniform cake.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 x 1g vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ertapenem
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems